Viewing Study NCT02655458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-02-20 @ 10:45 PM
Study NCT ID: NCT02655458
Status: COMPLETED
Last Update Posted: 2017-08-18
First Post: 2016-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma
Sponsor: Hearn Jay Cho
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None Induction Therapy View
None Autologous Stem Cell Transplant View
None ASCT View
None Auto-SCT View